United States· US:43063-122_41372f7a-4296-6e3d-e063-6394a90af659

Glimepiride

A glimepiride product containing glimepiride, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 17 of our 19 countries.

ATC A10BB12US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedGlimepirideATCA10BB12REGISTER NO.US:43063-122_41372f7a…PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Glimepiride is registered in 17 of 19 countries.

Countries holding a registration under ATC A10BB12 (glimepiride), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose

Glimepiride · ATC A10BB12

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glimepiride costs, country by country.

Normalised to the WHO defined daily dose (2 mg), the median price runs from $0.081 in Italy to $0.30 in Switzerland — a ×3.7 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Glimepiride · price per daily dose (2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.30
  • FR France$0.14
  • IT Italy$0.081
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
GLIMEPIRIDE
Manufacturer
PD-Rx Pharmaceuticals, Inc.
Country
United States (US)
ATC code
A10BB12
ATC class
Glimepiride
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    43063-122-30
  • ndc11
    43063-122-90
  • ndc11
    4306312230
    30 TABLET in 1 BOTTLE, PLASTIC (43063-122-30)
  • ndc11
    4306312290
    90 TABLET in 1 BOTTLE, PLASTIC (43063-122-90)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

723 interactions on record for glimepiride.

Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Glimepiride · interactions on record

723 records

  • 20 severe
  • 448 moderate
  • 47 minor
  • 208 info

Most severe, free to view

  • MiconazoleA07AC01severe
  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glimepiride in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glimepiride products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Glimepirid 1a Pharma, Glimepirid Hexal
  • Belgium · Glimepiride Eg, Glimepiride Sandoz
  • Bulgaria · Амарил, Глимегамма, Glimegamma
  • Cyprus · Amaryl, Dia-Ban
  • Czechia · Glimepirid Sandoz, Glimepirid Viatris
  • Germany · Amaryl, Glimepirid 1 A Pharma
  • Denmark · Glimepirid "sandoz", Glimepirid Bluefish
  • Estonia · Amaryl, Glimepiride Accord
  • Spain · Amaryl, Glimepirida Alter
  • Finland · Oltar, Priglide
  • France · Amarel, Glimepiride Accord Healthcare
  • United Kingdom (Northern Ireland) · Glimepiride Accord Healthcare, Glimepiride Bristol Laboratories
  • Greece · Anovis, Dia-Ban
  • Croatia · Amaryl, Melpamid
  • Hungary · Glimepirid 1 A Pharma, Glimepirid Hexal
  • Iceland · Glimeryl
  • Italy · Amaryl, Glimepiride Accord Healthcare
  • Lithuania · Amaryl
  • Luxembourg · Glimepiride Eg
  • Latvia · Amaryl
  • Malta · Glimepiride Aurobindo
  • Netherlands · Amaryl, Fertin
  • Norway · Glimepirid Teva
  • Poland · Amaryl, Amaryl 1
  • Portugal · Glimepirida Aurovitas, Glimepirida Ciclum
  • Romania · Amaryl
  • Sweden · Glimepirid Actavis, Glimepirid Bluefish
  • Slovakia · Glimepirid Sandoz, Melyd

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/89299c0e-f5bb-4b03-92fe-28324189f9c8
GET /v1/drugs/89299c0e-f5bb-4b03-92fe-28324189f9c8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "4",
  "substance": "GLIMEPIRIDE",
  "productndc": "43063-122",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA077091",
  "marketing_category": "ANDA"
}

See everything about glimepiride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.